December 17th, 2010
FDA Approves Cryoballoon Ablation Treatment for Paroxysmal AF
Larry Husten, PHD
Medtronic announced today that it has received FDA approval for its Arctic Front® Cardiac CryoAblation Catheter system for the treatment of refractory paroxysmal AF.
One Response to “FDA Approves Cryoballoon Ablation Treatment for Paroxysmal AF”
NEJM Journal Watch — Recent Cardiology Articles- Transcatheter Valve Replacement for Severe Tricuspid Regurgitation
- Time in Blood Pressure Target Range and Outcomes in Hypertension: Real-World Data
- When to Start Anticoagulation After Ischemic Stroke in Patients with Atrial Fibrillation
- Aortic-Valve Replacement vs. Clinical Surveillance for Asymptomatic Severe Aortic Stenosis
- Secondary Hypertension in Young Adults
Probably makes slightly more sense to be more circumspect and careful with an anti-platelet drug which will likely have a much wider clientele than a modality of therapy for paroxysmal resistant afib….